GSK (BSX) stock surged early Wednesday after the pharma giant reported adjusted earnings of 58 cents per share on $9.48 billion in fourth-quarter sales.
↑ X NOW PLAYING The Weight-Loss Drug Market Is Hot. Which Medical Stock Will Win The Battle For Supremacy?Analysts polled by FactSet expected GSK to earn 49 cents per share on $9.54 billion in sales.
In the year-earlier period, GSK reported earnings of 74 cents a share on $10.25 billion in sales.
For the year, the company guided to 3% to 5% sales growth and 6% to 8% core operating growth. The company also projects 6% to 8% growth in core earnings per share. Analysts forecasted earnings of $4.54 a share and $42.64 billion in sales.
GSK also bumped its 2031 sales outlook and now projects more than 40 billion pounds in sales, up from more than 38 billion pounds previously. That translates to roughly $50.05 billion, up from $47.55 billion, based on today's exchange rates.
In premarket trades on the stock market today, GSK stock charged 6.5% higher to 37.09.
More to follow.
YOU MAY ALSO LIKE:
Merck Stock Plummets 10% As Gardasil Dynamics, 2025 Guidance Weigh On Shares
RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
Want To Get Quick Profits And Avoid Big Losses? Try SwingTrader
How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.